Mercury elimination with oral DMPS, DMSA, vitamin C, and glutathione: An observational clinical review

Alternative Therapies in Health and Medicine

Volumn 12, Issue 3, 2006, Pages 70-75

  Muran, Peter J ^a  

^a Longevity Healthcare Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; DEXPANTHENOL; FLAVINE MONONUCLEOTIDE; FOLIC ACID; GLUCONATE CALCIUM; GLUTATHIONE; HYDROXOCOBALAMIN; MAGNESIUM; MERCURY; NICOTINAMIDE; PYRIDOXINE; RETINOL; SUCCIMER; THIAMINE; UNITHIOL; VITAMIN B GROUP;

BODY BURDEN; DETOXIFICATION; DRUG INFUSION; DRUG MEGADOSE; HUMAN; MERCURIALISM; OBSERVATIONAL METHOD; REVIEW; TISSUE LEVEL; URINE LEVEL;

ADULT; AGED; ASCORBIC ACID; CHELATING AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; GLUTATHIONE; HUMANS; KIDNEY; MALE; MERCURY; MERCURY POISONING; MIDDLE AGED; SUCCIMER; TREATMENT OUTCOME; UNITHIOL;

EID: 33646583500     PISSN: 10786791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Bolger PM, Schwetz BA. Mercury and health (Food and Drug Administration). N Engl J Med. 2002;347(22):1735-1736.
2. Clarkson TW, Magos L, Myers G. The toxicology of mercury - current exposures and clinical manifestations. N Engl J Med. 2003;349(18):1731-1737.
3. Comment on: N Engl J Med. 2003 Oct 30;349(18):1731-1737.
4. N Engl J Med. 2004;350(9):945-947; author reply 945-947.
5. Burger J, Gochfeld M. Mercury in canned tuna: white versus light and temporal variation. Environ Res. 2004;96(3):239-49.
6. Lindberg A, Bjornberg KA, Vahter M, Berglund M. Exposure to methyl mercury in non-fish-eating people in Sweden. Environ Res. 2004;96(1):28-33.
7. Quig D. Cysteine metabolism and metal toxicity. Altern Med Rev. 1998;3(4):262-270.
8. Davidson PW, Myers GJ. Weiss B. Mercury exposure and child development outcomes. Pediatrics. 2004;113:1023-1029.
9. Gatti R, Belletti S, Uggeri J, et al. Methylmercury cytotoxicity in PC12 cells is mediated by primary glutathione depletion independent of excess reactive oxygen species generation. Toxicology. 2004;204(2-3):175-185.
10. Sakamoto M, Kakita A, de Oliveira RB, Sheng Pan H, Takahashi H. Dose-dependent effects of methylmercury administered during neonatal brain spurt in rats. Brain Res Dev Brain Res. 2004;152(2):171-176.
11. Kidd PM. Autism, an extreme challenge to integrative medicine. Part 1: The knowledge base. Altern Med Rev. 2002;7(4):292-316.
12. Hock C, Drasch G, Golombowski S, et al. Increased blood mercury levels in patients with Alzheimer's disease. J Neural Transm. 1998;105(1)59-68.
13. Pelletier L, Pasquier R, Rossert J, Vial MC, Mandet C, Druet P. Autoreactive T cells in mercury-induced autoimmunity. Ability to induce the autoimmune disease. J Immunol. 1988;140(3):750-754.
14. Salonen JT, Seppanen K, Nyyssonen K, et al. Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation. 1995;91(3):645-655.
15. Salonen JT, Seppanen K, Lakka TA, et al. Mercury accumulation and accelerated progression of carotid atherosclerosis: a population-based prospective 4-year follow-up study in men in eastern Finland. Atherosclerosis. 2000;148(2):265-273.
16. Leong CC, Syed NI, Lorscheider FL. Retrograde degeneration of neurite membrane structural integrity of nerve growth cones following in vitro exposure to mercury. Neuroreport .2001;12(4):733-737.
17. Mahaffey KR, Clickner RP, Bodurow CC, Blood organic mercury and dietary mercury intake: national health and nutrition examination survey, 1999 and 2000. Environ Health Perspect. 2004;112(5):562-570.
18. Center for Disease Control and Prevention (CDC). Blood mercury levels in young children and childbearing-aged women - United States, 1999-2002. MMWR Morb Mortal Wkly Rep. 2004;53(43):1018-1020.
19. Cline J. Detoxfying specific toxicants. Paper presented at: Institute for Functional Medicine Conference; March 7, 2005; Seattle, Wash.
20. Buttar R. The treatment of cancer using immune modulating peptide analogs. Paper presented at: American College for Advancement in Medicine Conference; November 19, 2004; San Diego, Calif.
21. Hibberd AR, Howard MA, Hunnisett AG. Mercury from dental amalgam fillings: studies on oral chelating agents for accessing and reducing mercury burdens in humans. J Nutr & Env Med. 1998;8:219-231.
22. College Pharmacy DMPS Protocol. Pharmacy.info@collegepharmacy.com.
23. Aposhian HV, Maiorino RM, Gonzalez-Ramirez D, et al. Mobilization of heavy metals by newer, therapeutically useful chelating agents. Toxicology. 1995;97:23-38.
24. Roth E. Laboratory report for toxic metals. Doctors Data, Inc; St Charles, Ill.
25. Holmes A. Heavy metal toxicity in autistic spectrum disorders. Mercury toxicity. In: Rimland B, ed. DAN! (Defeat Autism Now!) Fall 2001 Conference Practitioner Training. San Diego, Calif: Autism Reseach Institute; 2002.
26. Cathcart RF. Mercury Chelation Protocol Los Altos, Calif: Medical Practice; 2002.
27. Kidd PM. Autism, an extreme challenge to integrative medicine. Part 2: medical management. Altern Med Review. 2002;7(6):472-499.
28. Ruprecht J. Scientific Monograph: Dimaval "DMPS." Heyltex Corp, 6th ed, 1997.
29. Aposhian HV, Maiorino R, Rivera M, et al. Human studies with the chelating agents, DMPS and DMSA. J Toxicol Clin Toxicol. 1992;30(4):505-528.
30. Aaseth J, Jacobsen D, Andersen O, Wickstrom E. Treatment of mercury and lead poisonings with dimercaptosuccinic acid (DMSA) and sodium dimercaptopropanesulfonate (DMPS). Analyst. 1995;120(3):853-854.
31. Chapman DW, Shaffer CF. Mercurial diuretics. A comparison of acute cardiac toxicity in animals and the effect of ascorbic acid on detoxification in their intravenous administration. Arch Intern Med. 1947;79:449-456.
32. Levy T. Vitamin C, Infectious Disease, and Toxins-Curing the Incurable. Philadelphia, Pa: Xlibris Corp; 2002:452.
33. Burns JJ, Rivers JM, Machlin LJ. Third Conference on Vitamin C. New York: New York Academy of Sciences; 1987.
34. Rea WJ. Chemical Sensitivity, vol 4. Boca Raton, Fla: CRC Press, Inc; 1997:2600.
35. Patrick L. Mercury toxicity and antioxidants: Part 1: role of glutathione and alpha-lipoic acid in the treatment of mercury toxicity. Altern Med Rev. 2002;7(6):456-471.
36. Cookson MR, Pentreath VW. Protective roles of glutathione in the toxicity of mercury and cadmium compounds to C6 glioma cells. Toxicol in Vitro. 1996;10(3):257-264.
37. Endo T, Sakata M. Effects of sulfhydryl compounds on the accumulation, removal and cytotoxicity of inorganic mercury by primary cultures of rat cortical epithelial cells. Pharmacol Taxicol. 1995;76(3):190-195.
38. Aposhian HV, Morgan DL, Queen HL, Maiorino RM, Aposhian MM. Vitamin C, glutathione, or lipoic acid did not decrease brain or kidney mercury in rats exposed to mercury vapor. J Toxicol Clin Toxicol. 2003;41(4):339-347.
39. Levy T. Vitamin C, calcium and circulation. Paper presented at the Society for Orthomolecular Health-Medicine Conference; February 25, 2005; San Francisco, Calif.
40. The Institute for Functional Medicine. Clinical Nutrition: A Functional Approach, 2nd edition. Gig Harbor, Wash: The Institute for Functional Medicine; 2004.
41. Yannai S, Berdicevsky I, Duek L. Transformations of inorganic mercury by Candida albicans and Saccharomyces cerevisiae. Appl Environ Microbiol. 1991;57(1):245-247.
42. Foster J, Kane P, Speight N. The Detoxx system: detoxification of biotoxins in chronic neurotoxic syndromes. Townsend Letter for Doctors & Patients. November 2002.